| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/30/2000 | EP1030859A1 Ras-binding protein (pre1) |
| 08/30/2000 | EP1030853A1 Novel signal transduction inhibitors, compositions containing them |
| 08/30/2000 | EP1030839A1 Use of alkylated iminosugars to treat multidrug resistance |
| 08/30/2000 | EP1030831A1 Process for the preparation of azacycloalkylalkanoyl pseudotetrapeptides |
| 08/30/2000 | EP1030819A1 Immunogenic conjugated polypeptide for treatment of herpes simplex virus |
| 08/30/2000 | EP1030690A1 Recombinant vaccines comprising immunogenic attenuated bacteria having rpos positive phenotype |
| 08/30/2000 | EP1030688A1 Method for decreasing self-association of polypeptides |
| 08/30/2000 | EP1030684A1 Modified antibodies with enhanced ability to elicit an anti-idiotype response |
| 08/30/2000 | EP1030683A1 Secretory leukocyte protease inhibitor dry powder pharmaceutical compositions |
| 08/30/2000 | EP1030682A1 Preparations for the treatment of metabolic syndrome containing human growth hormone in combination with a cortisol synthesis inhibitor |
| 08/30/2000 | EP1030681A1 Method and compositions for inhibiting angiogenesis and treating cancer |
| 08/30/2000 | EP1030680A1 Treatment of kaposi's sarcoma with il-12 |
| 08/30/2000 | EP1030679A1 Compositions and methods for promoting internalization and degradation of urokinase-type plasminogen activator |
| 08/30/2000 | EP1030674A1 METHODS FOR TREATMENT OF TUMORS AND TUMOR CELLS USING $i(EX VIVO) ACTIVATED T CELLS |
| 08/30/2000 | EP1030658A1 Method of building and maintaining bone |
| 08/30/2000 | EP1030656A1 Administering active substances by using the capsid produced out of the polyoma virus vp1 protein |
| 08/30/2000 | EP1030567A1 System, method and composition for dialysis and shock treatment |
| 08/30/2000 | EP1030557A1 Protein delivery by secretory gland expression |
| 08/30/2000 | EP0998251A4 Compositions and methods for inhibiting photoaging of skin |
| 08/30/2000 | EP0831876A4 Method of inhibiting viral replication in eukaryotic cells and of inducing apoptosis of virally-infected cells |
| 08/30/2000 | EP0765340B1 Methionine sulfone and s-substituted cysteine sulfone derivatives as enzyme inhibitors |
| 08/30/2000 | EP0759937B1 Peptides for inducing cytotoxic t lymphocyte responses to hepatitis c virus |
| 08/30/2000 | EP0742789B1 Pharmaceutically active compounds and liposomes, and methods of use therof |
| 08/30/2000 | EP0705274B1 Method and composition for treating thrombosis |
| 08/30/2000 | EP0687686B1 Aureobasidins |
| 08/30/2000 | EP0671946B1 Immunoreactive peptides from epstein-barr virus |
| 08/30/2000 | EP0668772B1 Specific immune system modulation |
| 08/30/2000 | EP0642348B1 Antibiotic cryptdin peptides and methods of their use |
| 08/30/2000 | EP0642343B1 Acridine carboxamides for the treatment of cancer |
| 08/30/2000 | EP0631501B1 Glycosylation-mediated inhibition of factor x |
| 08/30/2000 | EP0584290B1 Endothelin antagonists |
| 08/30/2000 | EP0584287B1 Purification of müllerian inhibiting substance for treatment of certain tumors |
| 08/30/2000 | EP0573605B1 Preparation of factor ix |
| 08/30/2000 | EP0248819B2 Recombinant fibroblast growth factors |
| 08/30/2000 | CN1265152A Prodn. of human mutant, proteins in human cells by homologous recombination |
| 08/30/2000 | CN1265149A Use of MHC class II ligands as adjuvant for vaccination and of LAG-3 in cancer treatment |
| 08/30/2000 | CN1265148A Anticoagulant fusion protein anchored to cell membrane |
| 08/30/2000 | CN1265144A Identification of human cell lines for prodn. of human proteins by endogenous gene activation |
| 08/30/2000 | CN1265143A Prodn. of erythropoietin by endogenous gene activation |
| 08/30/2000 | CN1265115A Streptogramines, their prepn. and compsns. containing them |
| 08/30/2000 | CN1265038A Cellular vesicle called 'exosome', prepn. and use thereof in immune stimulation |
| 08/30/2000 | CN1265036A Anti-coagulation of blood, blood plasma or synovial fluid products |
| 08/30/2000 | CN1264710A Modification and preparation of human interleukin 11 |
| 08/30/2000 | CN1264709A Human interleukin 11 derivative without amino acids at positions No.1-No.9 of N terminal |
| 08/30/2000 | CN1264599A Application of coenzyme NAD and its composition in cell-protecting medicines |
| 08/30/2000 | CN1264598A Gluconokinase microemulsion and preparing process thereof |
| 08/30/2000 | CN1264597A Eye drops for treating conjunctivitis and keratitis |
| 08/30/2000 | CN1264596A Polypeptide medicine as oral spray |
| 08/29/2000 | US6111095 Capped synthetic RNA, analogs, and aptamers |
| 08/29/2000 | US6111094 Enhanced antisense modulation of ICAM-1 |
| 08/29/2000 | US6111093 Nucleotide sequence of cd antigen; for diagnosis and immunotherapy of related immune disorders |
| 08/29/2000 | US6111092 Nucleic acid molecules encoding DRT111 and uses thereof |
| 08/29/2000 | US6111091 Nucleotide sequence of ionotropic glutamate receptor; probes to identify and isolate related human receptor subunits; drug screening assays to identify agonists, antagonists, and modulators |
| 08/29/2000 | US6111090 Isolated or recombinant polynucleotide encodes a polypeptide expressed on activated t cells; treatment and diagnosis of abnormal immune responses such as t cell immune deficiency; antiinflammatory agents; immunosuppressants |
| 08/29/2000 | US6111089 Nucleic acid encoding a defined mouse amino acid sequence of a protein involved in embryo implantation; vaccine can be used as antifertility agent |
| 08/29/2000 | US6111088 Nucleotide sequence encoding a 52 kDa Ro/SSA autoantigen |
| 08/29/2000 | US6111084 Sialyl lewis mimetics produced by solid phase synthesis; antiinflammatory agents |
| 08/29/2000 | US6111081 Lactoferrin variants and uses thereof |
| 08/29/2000 | US6111078 Staphylococcus aureus rsbU-1 |
| 08/29/2000 | US6111076 Human G-protein coupled receptor (HIBCD07) |
| 08/29/2000 | US6111075 Protese-activated receptor PAR4 (ZCHEMR2) |
| 08/29/2000 | US6111074 Amino acid sequence of polypeptide from the uridine monophosphate kinase family; for screening bactericides and bacteriostats; for diagnosis and prophylaxis of infections |
| 08/29/2000 | US6111069 Polypeptides that include conformation-constraining groups which flank a protein-protein interaction site |
| 08/29/2000 | US6111068 From the p-17 gag protein of human immunodeficiency virus; diagnosis; vaccines; viricides; prophylaxis and therapy for treating or suppressing acquired immune deficiency syndrome |
| 08/29/2000 | US6111067 Bactericides against grampositive bacteria |
| 08/29/2000 | US6111065 Inhibit neutrophil adhesion to p-selectin; antiinflammatory agents; anticoagulants; diagnostics |
| 08/29/2000 | US6110932 Increase the level of endogenous growth hormone for the treatment and prevention of osteoporosis, congestive heart failure, frailty associated with aging, obesity; accelerating bone fracture repair, accelerating wound healing |
| 08/29/2000 | US6110923 Method for treating cancer using novel substituted purinyl derivatives with immunomodulating activity |
| 08/29/2000 | US6110902 Method for the inhibition of neuronal activity leading to a focal epileptic seizure by local delivery of adenosine |
| 08/29/2000 | US6110899 LICC of Streptococcus pneumoniae |
| 08/29/2000 | US6110896 Peptidyl compounds and their therapeutic use |
| 08/29/2000 | US6110895 Method of promoting healing in skin grafts |
| 08/29/2000 | US6110894 Allosteric modulators of the NMDA receptor and their use in the treatment of CNS disorders and enhancement of CNS function |
| 08/29/2000 | US6110892 Peptides are derivatives of human parathyroid hormone (hpth) of given amino acid sequence which are cyclized in the form of a lactam between specified amino acid pairs; increased bioavailability |
| 08/29/2000 | US6110891 Prophylaxis or treatment of mucosal cell damage caused by a cell damaging agent such as chemotherapy and radiotherapy, by administering lectin to promote mucosal proliferation, counteracting the damage, and a cytoprotectant |
| 08/29/2000 | US6110890 Inducing resistance to dutch elm disease (ded) in a susceptible elm tree by administering to the tree a glycoprotein elicitor of specified amino acid sequence derived from a ded causing fungus to cause a defense reaction |
| 08/29/2000 | US6110889 Administering hexapeptides of amino acid sequence arg-arg-trp-trp-cys-arg to inhibit alpha-chemokine binding to the tumor cell |
| 08/29/2000 | US6110833 Elimination of oxynitride (ONO) etch residue and polysilicon stringers through isolation of floating gates on adjacent bitlines by polysilicon oxidation |
| 08/29/2000 | US6110747 Compounds and methods for modulating tissue permeability |
| 08/29/2000 | US6110746 Epitopes for early diagnosis of and antidiabetic agents for insulin-dependent diabetes; may be salts or functional derivatives such as chemical modification of amino acid side chains and/or carboxy and/or amino moieties |
| 08/29/2000 | US6110744 Diminishing viral gene expression by promoter replacement |
| 08/29/2000 | US6110743 Vector having at least two oncogenes, a pair of genetic elements which are recombination sites flanking the oncogenes, and another gene; for transformed cells which produce insulin and can be transplanted into human diabetic patients |
| 08/29/2000 | US6110742 Nucleotide sequences of nuclease resistant antisense agent which modulates acetylcholinesterase production in the central nervous system; treatment of alzheimer's disease with reduced side effects |
| 08/29/2000 | US6110741 Gonadotrophin releasor hormone-containing composition for embryo culture and method for in vitro fertilization |
| 08/29/2000 | US6110740 Human vault RNA |
| 08/29/2000 | US6110735 Method for the preparation of a viral vector by intermolecular homologous recombination |
| 08/29/2000 | US6110721 Isolated polypeptide at least about 80% homologous to and possesses at least one immune epitope of thrombin reference amino acid sequence; anticoagulants and procoagulants; diagnosis of blood disorders; drug screening; antitumor agents |
| 08/29/2000 | US6110719 Phytase |
| 08/29/2000 | US6110708 Recombinant conglutinin and producing method thereof |
| 08/29/2000 | US6110706 Amino acid sequences; for increased immunogenicity |
| 08/29/2000 | US6110705 Recombinant Chlamydia trachomatis pgp3 fusion protein |
| 08/29/2000 | US6110704 3-ketoacyl-ACP-reductase (FabG) of Staphylococcus aureus |
| 08/29/2000 | US6110701 DNA encoding precursor of interleukin-1β converting enzyme--related cysteine proteinase II (ICErel -II) |
| 08/29/2000 | US6110700 Nucleic acids that code a modulator of kinase activity; for the diagnosis tumorous condition; for development of models for the evaluation cancer in organ and tissues |
| 08/29/2000 | US6110697 Histone deacetylase as target for antiprotozoal agents |
| 08/29/2000 | US6110695 Detecting modulators of chemotaxis between lymphocyte attractant and burkitt's lymphoma receptor polypeptide; incubating a cell with attractant and modulator, detecting binding, calcium mobility or chemotaxis, compare to reference |
| 08/29/2000 | US6110694 Methods for determining complexes of tumor rejection antigens and HLA-Cw*160/molecules |
| 08/29/2000 | US6110688 Separating compounds from human urine; freezing human urine, thawing urine, separating precipitate by centrifuging, recovering precipitate, dissolvingin solution, dialysis, separating supernatant, isolate protein, detect with antibody |
| 08/29/2000 | US6110686 DNA hybridizing to a human cystatin-like protein (CSTIN) |
| 08/29/2000 | US6110685 Polynucleotide sequence coding translational activation polypeptide; for prevention of infecttion; bactericides; microbicides |